- Home
- ATRC vs ATUS Comparison
ATRC vs ATUS Comparison
Compare ATRC & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- ATUS
- Stock Information
- Founded
- ATRC 2000
- ATUS 2015
- Country
- ATRC United States
- ATUS United States
- Employees
- ATRC N/A
- ATUS N/A
- Industry
- ATRC Medical/Dental Instruments
- ATUS Cable & Other Pay Television Services
- Sector
- ATRC Health Care
- ATUS Telecommunications
- Exchange
- ATRC Nasdaq
- ATUS Nasdaq
- Market Cap
- ATRC 1.6B
- ATUS 1.0B
- IPO Year
- ATRC 2005
- ATUS 2017
- Fundamental
- Price
- ATRC $31.79
- ATUS $2.66
- Analyst Decision
- ATRC Strong Buy
- ATUS Buy
- Analyst Count
- ATRC 10
- ATUS 6
- Target Price
- ATRC $49.50
- ATUS $2.88
- AVG Volume (30 Days)
- ATRC 405.6K
- ATUS 4.9M
- Earning Date
- ATRC 07-29-2025
- ATUS 08-07-2025
- Dividend Yield
- ATRC N/A
- ATUS N/A
- EPS Growth
- ATRC N/A
- ATUS N/A
- EPS
- ATRC N/A
- ATUS N/A
- Revenue
- ATRC $480,076,000.00
- ATUS $8,855,764,000.00
- Revenue This Year
- ATRC $14.63
- ATUS N/A
- Revenue Next Year
- ATRC $12.62
- ATUS N/A
- P/E Ratio
- ATRC N/A
- ATUS N/A
- Revenue Growth
- ATRC 15.79
- ATUS N/A
- 52 Week Low
- ATRC $20.20
- ATUS $1.52
- 52 Week High
- ATRC $43.11
- ATUS $3.20
- Technical
- Relative Strength Index (RSI)
- ATRC 45.49
- ATUS 69.02
- Support Level
- ATRC $31.26
- ATUS $2.09
- Resistance Level
- ATRC $32.09
- ATUS $2.23
- Average True Range (ATR)
- ATRC 0.92
- ATUS 0.12
- MACD
- ATRC -0.07
- ATUS 0.07
- Stochastic Oscillator
- ATRC 40.65
- ATUS 96.58
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.